Login

Tomorrow's Company interviews Roger Parry CBE, Chairman of YouGov plc and Oxford Metrics plc, as well as Peter Taylor. 00:10:00

Share On Facebook Share On Twitter

Imogen Moorhouse is CEO/Exec Dir at Oxford Metrics PLC. 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Enhancing Productivity with Rugged, Reliable Technology for Challenging Environments|CEO,Winmate Inc
00:10:00
Blinder Diamond Project Overview
00:10:00
Derek Hensley - Wealth Advisor and Host of "Understanding Identity Theft Protection" Webinar | Derek Hensley - Wealth Advisor of Sound Stewardship, LLC
00:10:00
Fostering Renewable Energy and Community Resilience in Hawai | Shelee Kimura, CEO,Hawaiian Electric Industries Inc.
00:10:00
Exploring Greenland's Gold Potential: The Mamluk Altman Project
00:10:00
AR Revolutionizing Beauty Industry and Future of AR Commerce | Alice Chang, CEO, Perfect Corp.
00:10:00
Black-owned firm focused on startups shaping culture|Michael Palank,General Partner,MaC Venture Capital
00:10:00
Interview with Dr Daniel Matjila, CEO of Public Investment Corporation | Abel Sithole, CEO, Public Investment Corporation (SOC) Ltd.AS OF 31 AUG 2023
00:10:00
Challenges and Optimism: Assessing Brazil's Sanitation Future Through Expert Insights | Benedito Braga, CEO, Companhia de Saneamento Basico do Estado de Sao Paulo SABESP.
00:10:00
Pascal Soriot, CEO of AstraZeneca, believes that real innovation in healthcare requires bold thinking and a commitment to breakthrough science.
00:10:00
Reflecting on 2022: Lessons and 2023 Market Outlook | Richard S. Brown - CHAIRMAN & CHIEF EXECUTIVE OFFICER of JNBA Financial Advisors
00:10:00
David Elberstein on the Shifting Identity of the October 8th Jew|David L. Bernstein, Professor, George Mason University School of Law

© 2026 Nehu